🏢
AbbVie
ABBV · sp500
$256.46
-1.44% today
$217.72
Open
$258.91
High
$255.61
Low
$381.10B
Market cap
⏱️ Updated: 16:28 · ⚠️ ~15 min delay
🏢 About AbbVie
AbbVie is a global biopharmaceutical company that spun off from Abbott Laboratories in 2013. Its blockbuster drug Humira held the title of world's best-selling medicine for many years before patent expiry. AbbVie has built a diversified portfolio through the acquisition of Allergan, adding Botox and other aesthetics products, as well as developing new immunology and oncology drugs such as Skyrizi and Rinvoq.
📈 30-day price history
| Date | Close | Volume |
|---|---|---|
| 07 Sep | $256.46 | 4,701,126 |
| 04 Sep | $260.21 | 2,878,299 |
| 03 Sep | $261.72 | 4,223,114 |
| 02 Sep | $259.99 | 3,814,980 |
| 01 Sep | $256.42 | 4,238,123 |
| 31 Aug | $255.48 | 3,222,214 |
| 28 Aug | $258.15 | 4,759,390 |
| 27 Aug | $262.90 | 3,303,234 |
| 26 Aug | $265.79 | 3,669,103 |
| 25 Aug | $264.52 | 3,873,934 |
| 24 Aug | $264.96 | 5,135,044 |
| 21 Aug | $261.83 | 5,226,666 |
| 20 Aug | $265.97 | 5,492,517 |
| 19 Aug | $258.92 | 3,756,593 |
| 18 Aug | $250.33 | 4,647,028 |
| 17 Aug | $249.46 | 3,987,418 |
| 14 Aug | $250.82 | 3,469,563 |
| 13 Aug | $248.76 | 2,891,601 |
| 12 Aug | $250.09 | 3,105,400 |
| 11 Aug | $247.97 | 4,205,927 |
| 10 Aug | $246.04 | 4,699,891 |
| 07 Aug | $243.87 | 4,305,165 |
| 06 Aug | $246.20 | 5,086,089 |
| 05 Aug | $243.80 | 5,782,249 |
| 04 Aug | $245.10 | 5,777,474 |
| 03 Aug | $250.94 | 4,875,605 |
| 31 Jul | $257.41 | 6,398,916 |
| 30 Jul | $263.30 | 4,309,668 |
| 29 Jul | $263.20 | 5,188,767 |
| 28 Jul | $256.91 | 5,401,046 |